| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |